Abstract:Background: In our previous paper, we demonstrated that Connexin 43 (CX43) was highly expressed in bladder cancer (BC) tissues. But the molecular mechanism about microRNAs (miRNAs) regulation upstream of CX43 in BC has not been well elucidated and remains to be further studied. MicroRNA-139-5p (miR-139-5p) is a tumor suppressor in progression of multifarious cancers including BC. Nevertheless, the underlying mechanisms of CX43/miR-139-5p in tumorigenesis of BC are still not well illustrated. The specific objective of our study was to inquiry the effect of CX43/miR-139-5p on BC progression and its underlying mechanism. Methods: The bioinformatics analysis softwares were applied to predict the miRNAs in the upstream of CX43. First, the expression levels of miR-139-5p in BC tissues (tumor) and paracancer tissues (normal) were investigated using the data from The Cancer Genome Atlas database. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to detect the mRNA expression level of miR-139-5p in three human BC cell lines 5637, T24, ECV-304 and a human bladder epithelial immortalized cell line SV-HUC-1 (normal control). Then si-CX43, si-control, miR-139-5p mimic, and its negative control (NC) were transfected into BC cell line ECV-304. The relationship of miR-139-5p and CX43 was analyzed by dual-luciferase reporter assay. The qRT-PCR and Western blotting were used to test the mRNA and protein expression level of CX43. The proliferation of ECV-304 and T24 cells were examined by cell counting kit-8. The migration and invasion of ECV-304 cells were tested by transwell assay. To determine whether miR-139-5p would affect cell proliferation, migration and invasion by targeting CX43, we executed the rescue assay. The comparison between two groups was analyzed by Student's t test, and comparisons among multiple samples were performed by one-way analysis of variance and a Bonferroni post hoc test. Results: The expression of miR-139-5p was remarkably down-regulated in BC tissues (tumor vs. normal, 2.286 +/- 0.017 vs. 3.211 +/- 0.034, t = 11.540, P < 0.0001) and cell lines (P < 0.01 in all BC cell lines). Besides, we also indicated that over-expression of miR-139-5p reduced the proliferation of ECV-304 (P = 0.001) and T24 cells (P = 0.005). Moreover, miR-139-5p over-expression weakened the invasion (P = 0.001) and migration (P = 0.001) of ECV-304 cells. Furthermore, the relative luciferase activity of CX43-wild type construct was distinctly lessened by up-regulation of miR-139-5p (miR-139-5p mimic NC vs. miR-139-5p mimic, 0.916 +/- 0.063 vs. 0.356 +/- 0.048, t = 7.085, P = 0.002), nevertheless the activity of CX43-mutant type construct was untouched (miR-139-5p mimic NC vs. miR-139-5p mimic, 0.918 +/- 0.057 vs. 0.878 +/- 0.039, t = 0.577, P = 0.595). Finally, the rescue assay revealed that CX43 deletion enhanced the depressor effect of miR-139-5p on ECV-304 cell proliferation (P < 0.01), invasion (P = 0.028), and migration (P = 0.014). Conclusion: MiR-139-5p, as a tumor-suppressor, repressed cell proliferation, invasion, and migration in BC, which might be achieved by regulating CX43.

LINC00511/miRNA-143-3p Modulates Apoptosis and Malignant Phenotype of Bladder Carcinoma Cells via PCMT1

LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer

LncRNA CASC15 Functions As an Oncogene by Sponging Mir-130B-3p in Bladder Cancer.

Correction For: LncRNA PVT1 Accelerates Malignant Phenotypes of Bladder Cancer Cells by Modulating Mir-194-5p/bclaf1 Axis As a Cerna

MiR-362-5p, Which is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI

Long Non‑coding RNA 00858 Knockdown Alleviates Bladder Cancer Via Regulation of the Mir‑3064‑5p/ctgf Axis.

CCND1, NOP14 and DNMT3B Are Involved in Mir‐502‐5p–mediated Inhibition of Cell Migration and Proliferation in Bladder Cancer

The LINC01929/miR-6875-5p/ADAMTS12 Axis in the ceRNA Network Regulates the Development of Advanced Bladder Cancer

MiRNA-217 Accelerates the Proliferation and Migration of Bladder Cancer Via Inhibiting KMT2D.

Tumor-suppressor Microrna-139-5p Restrains Bladder Cancer Cell Line ECV-304 Properties Via Targeting Connexin 43

LncRNA00518 Promotes Cell Proliferation Through Regulating Mir-101 in Bladder Cancer.

Oncogene Mir-187-5p is Associated with Cellular Proliferation, Migration, Invasion, Apoptosis and an Increased Risk of Recurrence in Bladder Cancer.

High LINC00536 Expression Promotes Tumor Progression and Poor Prognosis in Bladder Cancer

Microarray Expression Profiles Analysis Revealed Lncrna OXCT1-AS1 Promoted Bladder Cancer Cell Aggressiveness Via Mir-455-5p/jak1 Signaling

LINC01410 leads the migration, invasion and EMT of bladder cancer cells by modulating miR-4319 / Snail1

KCNQ1OT1 aggravates cell proliferation and migration in bladder cancer through modulating miR-145-5p/PCBP2 axis

LINC00689 Promotes Prostate Cancer Progression Via Regulating Mir-496/Ctnnb1 to Activate Wnt Pathway

Long Non-Coding Rna Xist Promotes Cell Growth And Metastasis Through Regulating Mir-139-5p Mediated Wnt/Beta-Catenin Signaling Pathway In Bladder Cancer

&Lt;p>lncrna HCP5 Promotes Cell Invasion and Migration by Sponging Mir-29B-3p in Human Bladder Cancer</p>

MicroRNA-143 As a Tumor Suppressor for Bladder Cancer.

LINC00978 Promotes Bladder Cancer Cell Proliferation, Migration and Invasion by Sponging Mir‑4288.